Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis

被引：92

作者：

Sobel, BE ^{[1
]}

Taatjes, DJ ^{[1
]}

Schneider, DJ ^{[1
]}

机构：

[1] Univ Vermont, Coll Med, Burlington, VT USA

来源：

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2003年 / 23卷 / 11期

关键词：

vulnerable plaques; diabetes; fibrinolysis; atherothrombosis; coronary artery disease;

D O I：

10.1161/01.ATV.0000091250.53231.4D

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Altered expression of plasminogen activator inhibitor type- 1 in vessel walls, reviewed here, might affect coronary atherogenesis. Upregulation might exacerbate vasculopathy by potentiating thrombosis and by inhibiting vascular smooth muscle cell migration, resulting in attenuation of thickness of elaborated fibrous caps implicated in the vulnerability of atheroma to rupture.

引用

收藏

页码：1979 / 1989

页数：11

相关论文

共 160 条

[1] Concentration of serum lipids and aortic lesion size in female and male apo E-deficient mice fed docosahexaenoic acid [J].

Adan, Y ;

Shibata, K ;

Ni, WH ;

Tsuda, Y ;

Sato, M ;

Ikeda, I ;

Imaizumi, K .

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1999, 63 (02) :309-313

[2] Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages [J].

Aiello, RJ ;

Brees, D ;

Bourassa, PA ;

Royer, L ;

Lindsey, S ;

Coskran, T ;

Haghpassand, M ;

Francone, OL .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (04) :630-637

[3] Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease - The bypass angioplasty revascularization investigation (BARI) [J].

Alderman, E ;

Bourassa, M ;

Brooks, MM ;

Califf, R ;

Chaitman, B ;

Detre, K ;

Faxon, DP ;

Feit, F ;

Frye, RL ;

Hardison, RM ;

Holmes, D ;

Holubkov, R ;

Kouchoukos, N ;

Krone, R ;

Rogers, W ;

Rosen, AD ;

Schaff, H ;

Schwartz, L ;

Siewers, AS ;

Sopko, G ;

SuttonTyrrell, K ;

Whitlow, P .

CIRCULATION, 1997, 96 (06) :1761-1769

[4] Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells [J].

Allison, BA ;

Nilsson, L ;

Karpe, F ;

Hamsten, A ;

Eriksson, P .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (05) :1354-1360

[5] MONOCYTIC ORIGIN OF FOAM CELLS IN HUMAN ATHEROSCLEROTIC PLAQUES [J].

AQEL, NM ;

BALL, RY ;

WALDMANN, H ;

MITCHINSON, MJ .

ATHEROSCLEROSIS, 1984, 53 (03) :265-271

[6] Transcriptional regulation of plasminogen activator inhibitor type I gene by insulin - Insights into the signaling pathway [J].

Banfi, C ;

Eriksson, P ;

Giandomenico, G ;

Mussoni, L ;

Sironi, L ;

Hamsten, A ;

Tremoli, E .

DIABETES, 2001, 50 (07) :1522-1530

[7] Role of smooth muscle cell death in advanced coronary primary lesions:: implications for plaque instability [J].

Bauriedel, G ;

Hutter, R ;

Welsch, U ;

Bach, R ;

Sievert, H ;

Lüderitz, B .

CARDIOVASCULAR RESEARCH, 1999, 41 (02) :480-488

[8] EVIDENCE FOR A MONOCLONAL ORIGIN OF HUMAN ATHEROSCLEROTIC PLAQUES [J].

BENDITT, EP ;

BENDITT, JM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (06) :1753-1756

[9] Reduced early insulin secretion in the etiology of type 2 diabetes mellitus in Pima Indians [J].

Bogardus, C ;

Tataranni, PA .

DIABETES, 2002, 51 :S262-S264

[10] A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice [J].

Boisvert, WA ;

Santiago, R ;

Curtiss, LK ;

Terkeltaub, RA .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :353-363

← 1 2 3 4 5 6 7 8 9 10 →